Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Find a clinical trial that's recruiting now
Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.
- 24,857
- trials recruiting now
- 14%
- of all US trials open to enrollment
- 52
- states with recruiting sites
A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.
Popular conditions
100 trials found
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
St. Jude Children's Research Hospital
NCT01354002
Caris Biorepository Research Protocol
Caris Science
NCT01499394
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
University of California, San Francisco
NCT02620852
International Weight Control Registry
Tufts University
NCT04907396
Registry Study for Radiation Therapy Outcomes
Proton Collaborative Group
NCT01255748
Pennington Center Longitudinal Study (PCLS)
Pennington Biomedical Research Center
NCT00959270
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
UMC Utrecht
NCT02735707
Sickle Cell Clinical Research and Intervention Program
St. Jude Children's Research Hospital
NCT02098863
Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology
Tulane University
NCT06753045
Innovations in Genicular Outcomes Registry
Pacira Pharmaceuticals
NCT05495334
Nutrition for Precision Health, Powered by the All of Us
RTI International
NCT05701657
Non-Invasive Preeclampsia Screening and Biobank
Sequenom
NCT06643741
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Pfizer
NCT07160244
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Persephone Biosciences
NCT04638751
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Prostate Cancer Clinical Trials Consortium
NCT03151629
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
HistoSonics
NCT06486454
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Boston Scientific Corporation
NCT04674969
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Duke University
NCT04278404
Observational Study Protocol: LIVER-R
AstraZeneca
NCT06252753
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Merck Sharp & Dohme
NCT07044297
The Fourth Left Atrial Appendage Occlusion Study
Hamilton Health Sciences Corporation
NCT05963698
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
University of Manitoba
NCT05848713
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49
Vaxcyte
NCT07284654
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Icahn School of Medicine at Mount Sinai
NCT04045665
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Mayo Clinic
NCT05051722
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Duke University
NCT01915511
Real World Registry for Use of the Ion Endoluminal System
Intuitive Surgical
NCT06004440
Pennington Generation Cohort
Pennington Biomedical Research Center
NCT06849206
Pulmonary Hypertension Association Registry
Pulmonary Hypertension Association
NCT04071327
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Merck Sharp & Dohme
NCT06966700
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Veracyte
NCT06426628
Motiva Implants® Post-Approval Study
Motiva USA
NCT06938399
CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting
Corcym S.r.l
NCT05002543
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Guardant Health
NCT05059444
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
Jason Sperry
NCT04100564
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
Uppsala University
NCT02901184
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
W.L.Gore & Associates
NCT06218875
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
Michael J. Fox Foundation for Parkinson's Research
NCT06719583
Pancreatic Cancer Detection Consortium
City of Hope Medical Center
NCT06388967
Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
Karius
NCT07110636
Evaluation of Are You Ready?
The Policy & Research Group
NCT06580080
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
Insud Pharma
NCT05303636
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Boehringer Ingelheim
NCT06238622
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Kailera
NCT07284901
Prospective Study to Assess a Diagnostic Aid for Cancer
Harbinger Health
NCT07046260
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
M.D. Anderson Cancer Center
NCT06651580
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Janssen Research & Development
NCT05552222
Evaluation of Unstained
The Policy & Research Group
NCT06574139
Spinal Cord Injury Registry - North American Clinical Trials Network
Robert G. Grossman, MD
NCT00178724
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)
Colorado Prevention Center
NCT06024746
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Boston Scientific Corporation
NCT06827262
Complex Adult Deformity Surgery (CADS)
International Spine Study Group Foundation
NCT04194138
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Sparrow Pharmaceuticals
NCT07296484
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Incyte Corporation
NCT05919511
Evaluation of Peer Group Connection - Middle School
The Policy & Research Group
NCT06582641
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Merck Sharp & Dohme
NCT06136624
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
Ipsen
NCT07435428
Collection of Samples USOPTIVAL Study
Universal Diagnostics
NCT04792684
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Global Coalition for Adaptive Research
NCT03970447
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Novo Nordisk A/S
NCT07207811
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
AstraZeneca
NCT06921785
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Kailera
NCT07284979
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
Eli Lilly and Company
NCT06993792
Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole
Tulane University
NCT06261840
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Merck Sharp & Dohme
NCT06312176
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Regeneron Pharmaceuticals
NCT07175428
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT
Major Extremity Trauma Research Consortium
NCT04678154
Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)
Tulane University
NCT06133322
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Merck Sharp & Dohme
NCT06952504
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
University of Alabama at Birmingham
NCT05638581
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
ModernaTX
NCT06585241
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Merck Sharp & Dohme
NCT07216703
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Abbott Medical Devices
NCT04071847
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
United Therapeutics
NCT06388421
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
Aptitude Medical Systems
NCT06744660
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Pacific Edge Limited
NCT06394869
Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage
Baymatob Operations Pty
NCT06655207
Global Paradise System US Post Approval Study
ReCor Medical
NCT06297291
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
Philip Spinella
NCT06070350
A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD
Cleerly
NCT06713239
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Merz Therapeutics
NCT07018700
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
BicycleTx Limited
NCT06225596
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Pfizer
NCT05020236
Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention
University of Chicago
NCT05723653
The Dose Trial: Dose Intensity of Behavioral Interventions for Childhood Obesity
Vanderbilt University Medical Center
NCT06654323
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
AstraZeneca
NCT04862663
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
GlaxoSmithKline
NCT05855200
CTSN Embolic Protection Trial
Icahn School of Medicine at Mount Sinai
NCT06027788
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
ModernaTX
NCT07089706
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Celgene
NCT05519085
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
Tulane University
NCT06065098
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
AstraZeneca
NCT06079671
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Eli Lilly and Company
NCT07369011
Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children
University of Illinois at Urbana-Champaign
NCT05639465
Myriad™ Augmented Soft Tissue Reconstruction Registry
Aroa Biosurgery Limited
NCT05243966
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Janssen Research & Development
NCT07225946
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio
NCT05150691
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
Janssen Research & Development
NCT06208150
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
BeiGene
NCT05100862
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Merz Therapeutics
NCT07018713
Read our methodology - how recruiting status is sourced and refreshed from the public registry.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.